Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

276 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary Hypertension.
Nikolic I, Yung LM, Yang P, Malhotra R, Paskin-Flerlage SD, Dinter T, Bocobo GA, Tumelty KE, Faugno AJ, Troncone L, McNeil ME, Huang X, Coser KR, Lai CSC, Upton PD, Goumans MJ, Zamanian RT, Elliott CG, Lee A, Zheng W, Berasi SP, Huard C, Morrell NW, Chung RT, Channick RW, Roberts KE, Yu PB. Nikolic I, et al. Among authors: roberts ke. Am J Respir Crit Care Med. 2019 Apr 1;199(7):891-902. doi: 10.1164/rccm.201807-1236OC. Am J Respir Crit Care Med. 2019. PMID: 30312106 Free PMC article.
BMP9/10 in Pulmonary Vascular Complications of Liver Disease.
Rochon ER, Krowka MJ, Bartolome S, Heresi GA, Bull T, Roberts K, Hemnes A, Forde KA, Krok KL, Patel M, Lin G, McNeil M, Al-Naamani N, Roman BL, Yu PB, Fallon MB, Gladwin MT, Kawut SM. Rochon ER, et al. Am J Respir Crit Care Med. 2020 Jun 15;201(12):1575-1578. doi: 10.1164/rccm.201912-2514LE. Am J Respir Crit Care Med. 2020. PMID: 32083953 Free PMC article. No abstract available.
Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease.
Roberts KE, Fallon MB, Krowka MJ, Brown RS, Trotter JF, Peter I, Tighiouart H, Knowles JA, Rabinowitz D, Benza RL, Badesch DB, Taichman DB, Horn EM, Zacks S, Kaplowitz N, Kawut SM; Pulmonary Vascular Complications of Liver Disease Study Group. Roberts KE, et al. Am J Respir Crit Care Med. 2009 May 1;179(9):835-42. doi: 10.1164/rccm.200809-1472OC. Epub 2009 Feb 12. Am J Respir Crit Care Med. 2009. PMID: 19218192 Free PMC article.
Portopulmonary hypertension.
Al-Naamani N, Roberts KE. Al-Naamani N, et al. Among authors: roberts ke. Clin Chest Med. 2013 Dec;34(4):719-37. doi: 10.1016/j.ccm.2013.08.008. Clin Chest Med. 2013. PMID: 24267301 Review.
Higher Estradiol and Lower Dehydroepiandrosterone-Sulfate Levels Are Associated with Pulmonary Arterial Hypertension in Men.
Ventetuolo CE, Baird GL, Barr RG, Bluemke DA, Fritz JS, Hill NS, Klinger JR, Lima JA, Ouyang P, Palevsky HI, Palmisciano AJ, Krishnan I, Pinder D, Preston IR, Roberts KE, Kawut SM. Ventetuolo CE, et al. Among authors: roberts ke. Am J Respir Crit Care Med. 2016 May 15;193(10):1168-75. doi: 10.1164/rccm.201509-1785OC. Am J Respir Crit Care Med. 2016. PMID: 26651504 Free PMC article.
Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension.
Willers ED, Newman JH, Loyd JE, Robbins IM, Wheeler LA, Prince MA, Stanton KC, Cogan JA, Runo JR, Byrne D, Humbert M, Simonneau G, Sztrymf B, Morse JA, Knowles JA, Roberts KE, McElroy JJ, Barst RJ, Phillips JA 3rd. Willers ED, et al. Among authors: roberts ke. Am J Respir Crit Care Med. 2006 Apr 1;173(7):798-802. doi: 10.1164/rccm.200509-1361OC. Epub 2005 Dec 9. Am J Respir Crit Care Med. 2006. PMID: 16339917 Free PMC article.
Plasma levels of S100A4 in portopulmonary hypertension.
Peng T, Zamanian R, Krowka MJ, Benza RL, Roberts KE, Taichman DB, Rybak D, Trotter JF, Brown RS Jr, Fallon MB, Kawut SM; Pulmonary Vascular Complications of Liver Disease Study Group. Peng T, et al. Among authors: roberts ke. Biomarkers. 2009 May;14(3):156-60. doi: 10.1080/13547500902773896. Biomarkers. 2009. PMID: 19399660 Free PMC article.
Clinical risk factors for portopulmonary hypertension.
Kawut SM, Krowka MJ, Trotter JF, Roberts KE, Benza RL, Badesch DB, Taichman DB, Horn EM, Zacks S, Kaplowitz N, Brown RS Jr, Fallon MB; Pulmonary Vascular Complications of Liver Disease Study Group. Kawut SM, et al. Among authors: roberts ke. Hepatology. 2008 Jul;48(1):196-203. doi: 10.1002/hep.22275. Hepatology. 2008. PMID: 18537192 Free PMC article.
Inhaled Therapies for Pulmonary Hypertension.
Hill NS, Preston IR, Roberts KE. Hill NS, et al. Among authors: roberts ke. Respir Care. 2015 Jun;60(6):794-802; discussion 802-5. doi: 10.4187/respcare.03927. Respir Care. 2015. PMID: 26070575 Free article. Review.
Estrogen Signaling and Portopulmonary Hypertension: The Pulmonary Vascular Complications of Liver Disease Study (PVCLD2).
Al-Naamani N, Krowka MJ, Forde KA, Krok KL, Feng R, Heresi GA, Dweik RA, Bartolome S, Bull TM, Roberts KE, Austin ED, Hemnes AR, Patel MJ, Oh JK, Lin G, Doyle MF, Denver N, Andrew R, MacLean MR, Fallon MB, Kawut SM; , for the Pulmonary Vascular Complications of Liver Disease Study Group. Al-Naamani N, et al. Among authors: roberts ke. Hepatology. 2021 Feb;73(2):726-737. doi: 10.1002/hep.31314. Epub 2020 Sep 29. Hepatology. 2021. PMID: 32407592 Free PMC article.
276 results